Novartis AG ADR (NYSE:NVS) - Share price - Overview

Stock Report

Novartis AG NVS

Last Price
$84.94

Day Change
-0.84|-0.98%

As of 21/09/2017
18:50:00 EDT | USD
Minimum 15 Minutes Delay.

Last Close85.78
Day Range84.90 - 85.56
Mkt Cap200.10Bil
52-Wk Range66.93 - 86.90
Yield %3.20
ISINUS66987V1098
Volume1,235,460
P/E31.00
P/S4.13
P/CF16.31

Share Price

Financials
201420152016
More ...
Income Statement
Revenue53,634.0050,387.0049,436.00
Operating Income11,089.008,977.008,268.00
Net Income10,210.0017,783.006,712.00
Basic EPS4.217.402.82
Avg. Diluted Shares Outstanding2,4262,4032,400
Balance Sheet
Current Assets37,561.0022,845.0024,931.00
Non Current Assets87,826.00108,711.00105,193.00
Total Assets125,387.00131,556.00130,124.00
Current Liabilities26,973.0023,708.0022,209.00
Total Liabilities54,621.0054,510.0055,292.00
Total Equity70,766.0077,046.0074,832.00
Cash Flow
Operating Cash Flow13,897.0011,897.0011,475.00
Capital Expenditure-3,404.00-3,505.00-2,879.00
Free Cash Flow10,493.008,392.008,596.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

Novartis AG is a part of the healthcare industry. Its main activity is to research and develop healthcare products and pharmaceuticals such as oncology medicines, generic and biosimilar medicines and eye care devices.

Sector

Healthcare

Industry

Drug Manufacturers - Major

Stock Style

Large-Blend

Fiscal Year Ends

December

Employees

119,000
Key Stats
More ...
Price/Earning TTM31.08
Price/Book2.87
Price/Sales TTM4.17
Rev Growth (3 year avg)-5.63
EPS Growth (3 year avg)-
Operating Margin % TTM16.72
Net Margin % TTM13.58
ROE TTM8.84
Debt/Equity0.24
Dividends
PreviousLatest
More ...
Declared Date25/01/1606/02/17
Ex-Div24/02/1601/03/17
Paid15/04/1620/04/17
Amnt2.722.72
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.